Skip to main content
OpenTrials
Completed

NCT Number: NCT02320695

Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping Injury

The purpose of this study is to have subjects report whether or not several antibiotic products sting when they are applied to minor wounds created on the inner arms.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The primary objective of this study is to assess the sting potential of single applications of over-the-counter (OTC) topical antibiotic ointments and cream compared to saline (negative control) and isopropyl alcohol (positive control) when applied to a tape-stripped wound site.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males and females, 18-75 years of age, of any race or ethnicity, in generally good health as determined by a medically-qualified individual
  • Provide a signed and dated informed consent form prior to start of any study-related procedures
  • Able to comprehend and follow the requirements of the study;
  • Females of childbearing potential must have a negative urine pregnancy test at the Screening/Baseline visit;
  • Male or non-pregnant, non-lactating females agree to the contraceptive requirements (including female partner's use of a highly effective form of birth control. Females must have used the same birth control for 1 month before Screening and continue to use it through 1 month after administration of study drug)
  • Willing and able to comply with the tape stripping and all study procedures and attend the scheduled visits for the duration of the study

Exclusion criteria

  • Suspected alcohol or substance abuse (e.g., amphetamines, benzodiazepines, cocaine, marijuana, opiates)
  • Females who are pregnant (positive urine pregnancy test at screening/baseline) or breastfeeding
  • Males with a pregnant partner or a partner who is currently trying to become pregnant
  • Using steroidal medication (topical or systemic) currently and within 30 days before Visit 1
  • Ingestion of systemic anti-histamines or analgesics within the 3 days before Visit 1
  • Known sensitivity or allergies to the investigational products, to first aid preparations or local anesthetics (e.g. gauze products, pramoxine), or to adhesive bandages
  • Known allergies to unscented soap
  • Tendency of forming keloids after wounding
  • Tattoos located on the surface of one or both inner (volar) region of forearms
  • Heavily pigmented subjects who could heal with abnormal darkening at the test sites on the inner forearms
  • Presence of excessive hair on the inner forearms which could interfere with the test procedures
  • Presents with skin disorders on the inner arms (cuts, scratches, scars, etc), which in the opinion of the Investigator or qualified designee, will interfere with the study assessment or will create undue risk for the subject
  • Pre-existing or dormant dermatologic skin conditions (e.g., eczema, seborrheic dermatitis, atopic dermatitis, psoriasis, vitiligo, etc.) that could interfere with the outcome of the study as determined by the Investigator or qualified designee
  • Other medical condition that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study

Treatment and study plan

Saline

Drug

Other names: Sterile 0.9% Sodium Chloride Saline Solution

Isopropyl Alcohol

Drug

Other names: 70 % Isopropyl Alcohol

Pain Relieving Cream

Drug

Other names: Neosporin® Plus Pain Relieving Cream formula with pH balance technology

Antibiotic/Pain Relieving Ointment

Drug

Other names: Neosporin® Complete First Aid Antibiotic/Pain Relieving Ointment

Original Ointment

Drug

Other names: Neosporin® Original Ointment

Pain Relief Ointment

Drug

Other names: Neosporin® Plus Pain relief Ointment

Primary outcomes

  1. Mean Change From Post-Tape Stripping in Subject Assessment of Stinging Sensation Immediately After Investigational Product Application

    Time frame: Post-tape stripping to immediately after investigational product application

    The stinging sensation was assessed by the subject using the following scale: 0 = no stinging sensation, 1 = mild stinging sensation, 2 = moderate stinging sensation, and 3 = severe stinging sensation at post-tape stripping and immediately after product application. Change from post-tape striping was calculated as the subject assessment of stinging sensation immediately after investigational product application minus the subject assessment of stinging sensation at post-tape stripping.

  2. Mean Change From Post-Tape Stripping in Subject Assessment of Stinging Sensation One Minute After Investigational Product Application

    Time frame: Post-tape stripping to one minute after investigational product application

    The stinging sensation was assessed by the subject using the following scale: 0 = no stinging sensation, 1 = mild stinging sensation, 2 = moderate stinging sensation, and 3 = severe stinging sensation at post-tape stripping and one minute after investigational product application. Change from post-tape striping was calculated as the subject assessment of stinging sensation at one minute after investigational product application minus the subject assessment of stinging sensation at post-tape stripping.

Secondary outcomes

  1. Mean Clinician Rating of Overall Wound Condition on Day 1

    Time frame: Day 1

    The clinician evaluated the wound using the following scale: 0 = minimal severity, 10 = maximal severity.

  2. Mean Clinician Rating of Overall Wound Condition on Day 8

    Time frame: Day 8

    The clinician evaluated the wound using the following scale: 0 = minimal severity, 10 = maximal severity.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Consumer and Personal Products Worldwide

Industry

Registry information

Official study title

Evaluation of Perception of Sting Sensation Following Application of Antibiotic Ointment and Cream Formulations After Tape Stripping Injury

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Dec 19, 2014
Registry last updated
Jan 5, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.